Data / Form D filings / RenovoRx, Inc.
RenovoRx, Inc.: Form D filings
RenovoRx, Inc., a biotechnology company in Mountain View, CA, filed 7 Form D notices with the SEC between 2013 and 2026. The latest, on April 9, 2026, reports $10 million sold of a $10 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2570 W EL CAMINO REAL, SUITE 320, Mountain View, CA, 94040
- Phone
- (650) 284-4433
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1574094
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | New notice | $10,000,000 | $9,999,929 | $71 | 16 | Mar 20, 2026 | sec.gov |
| Apr 22, 2024 | New notice | $15,000,000 | $11,136,557 | $3,863,443 | 172 | Apr 11, 2024 | sec.gov |
| Feb 9, 2024 | New notice | $15,000,000 | $6,111,695 | $8,888,305 | 92 | Jan 26, 2024 | sec.gov |
| Jun 19, 2018 | New notice | $13,744,992 | $8,309,774 | $5,435,218 | 21 | Apr 18, 2018 | sec.gov |
| Jan 5, 2016 | New notice | $2,099,999 | $2,099,999 | 18 | Dec 7, 2015 | sec.gov | |
| Dec 23, 2013 | New notice | $1,150,000 | $1,140,000 | $10,000 | 11 | Dec 20, 2013 | sec.gov |
| Apr 10, 2013 | New notice | $698,625 | $660,000 | $38,625 | 8 | Jan 23, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shaun R. Bagai | Executive Officer, Director | |
| Mark Voll | Executive Officer | |
| Leesa Gentry | Executive Officer | |
| Ramtin Agah | Executive Officer | |
| Laurence J. Marton | Director | |
| Una S. Ryan | Director | |
| Kirsten Angela Macfarlane | Director | |
| Robert J. Spiegel | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 6, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RenovoRx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.